Table 1. Patient baseline characteristics.
| Clinical parameter | Median [IQR] or n [%] |
|---|---|
| Age | 67 [12] |
| Male sex | 45 [85.3] |
| BMI | 27.2 [5.8] |
| Stage | |
| II | 12 [22.3] |
| III | 40 [74] |
| IV | 2 [3.7] |
| Dose | 5,040 |
| Histology | |
| Squamous cell carcinoma | 11 [20.4] |
| Adenocarcinoma | 42 [77.7] |
| Small cell | 1 [1.9] |
| Diabetes | 18 [33.3] |
| CAD | 11 [20.3] |
| Definitive CRT | 18 [33.3] |
| Proximal location | 10 [18] |
| Chemotherapy regimens | |
| Carboplatin/paclitaxol | 37 [68.5] |
| Other platin based | 17 [31.5] |
| Induction chemo | 7 [14.7] |
| 3D-conformal | 31 [57.4] |
| Baseline lymphocyte count | 1.83 [1.01] |
| Nadir absolute lymphocyte count | 0.26 [0.205] |
| Grade 4 lymphopenia events | 21 [38.8] |
| 3 months post CRT lymphocyte count | 0.61 [0.6] |
Continuous variables are expressed as median [interquartile range] and categorical variables as n [%].